Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study
Impacto
Scholar |
Otros documentos de la autoría: Arroyo, David; Betriu, Angels; Valls, Joan; Górriz, José Luis; Pallarés-Carratalá, Vicente; Abajo, María; Gracia, Marta; Valdivielso, José Manuel; Fernández, Elvira
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONEste recurso está restringido
https://doi.org/10.1093/ndt/gfw039 |
Metadatos
Título
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA studyAutoría
Fecha de publicación
2017Editor
Oxford University PressISSN
0931-0509; 1460-2385Cita bibliográfica
David Arroyo, Angels Betriu, Joan Valls, Jose L. Gorriz, Vicente Pallares, Maria Abajo, Marta Gracia, Jose Manuel Valdivielso, Elvira Fernandez, on behalf of the investigators from the NEFRONA study; Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study. Nephrol Dial Transplant 2017; 32 (3): 513-520. doi: 10.1093/ndt/gfw039Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://academic.oup.com/ndt/article/32/3/513/3059407/Factors-influencing-pathol ...Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Background: The ankle-brachial index (ABI) is widely used to
diagnose subclinical peripheral artery disease (PAD) in the general
population, but data assessing its prevalence and related factors
in different chronic ... [+]
Background: The ankle-brachial index (ABI) is widely used to
diagnose subclinical peripheral artery disease (PAD) in the general
population, but data assessing its prevalence and related factors
in different chronic kidney disease (CKD) stages are scarce.
The aim of this study is to evaluate the prevalence and associated
factors of pathological ABI values in CKD patients.
Methods: NEFRONA is a multicentre prospective project that
included 2445 CKD patients from 81 centres and 559 non-CKD
subjects from 9 primary care centres across Spain. A trained
team collected clinical and laboratory data, performed vascular
ultrasounds and measured the ABI.
Results: PAD prevalence was higher in CKD than in controls (28.0
versus 12.3%, P < 0.001). Prevalence increased in more advanced
CKD stages, due to more patients with an ABI 1.4, rather than
0.9. Diabetes was the only factor predicting both pathological
values in all CKD stages. Age, female sex, carotid plaques, higher
carotid intima-media thickness, higher high-sensitivity C-reactive
protein (hsCRP) and triglycerides, and lower 25-hydroxi-vitamin
D were independently associated with an ABI 0.9. Higher phosphate
and hsCRP, lower low-density lipoprotein (LDL)-cholesterol
and dialysis were associated with an ABI 1.4. A stratified analysis
showed different associated factors in each CKD stage, with phosphate
being especially important in earlier CKD, and LDLcholesterol
being an independent predictor only in Sage 5D CKD.
Conclusions: Asymptomatic PAD is very prevalent in all CKD
stages, but factors related to a low or high pathological ABI differ,
revealing different pathogenic pathways. Diabetes, dyslipidaemia,
inflammation and mineral-bone disorders play a role in
the appearance of PAD in CKD. [-]
Publicado en
Nephrol Dial Transplant (2017) 32: 513–520Derechos de acceso
© The Author 2016. Published by Oxford University Press
on behalf of ERA-EDTA. All rights reserved.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
Aparece en las colecciones
- MED_Articles [667]